Page 821 - Withrow and MacEwen's Small Animal Clinical Oncology, 6th Edition
P. 821
CHAPTER 34 Miscellaneous Tumors 799
34. Eberle N, von Babo V, Nolte I, et al.: Splenic masses in dogs. Part 57. Kraje AC, Mears EA, Hahn KA, et al.: Unusual metastatic behav-
1: epidemiologic, clinical characteristics as well as histopathologic ior and clinicopathologic findings in eight cats with cutaneous
diagnosis in 249 cases (2000-2011), Tierarztl Prax Ausg K Kleintiere or visceral hemangiosarcoma, J Am Vet Med Assoc 214:670–672,
VetBooks.ir 35. Aronsohn M: Cardiac hemangiosarcoma in the dog: a review of 38 58. McAbee KP, Ludwig LL, Bergman PJ, et al.: Feline cutaneous hem-
1999.
Heimtiere 40:250–260, 2012.
cases, J Am Vet Med Assoc 187:922–926, 1985.
Anim Hosp Assoc 41:110–116, 2005.
36. Yamamoto S, Hoshi K, Hirakawa A: Epidemiological, clinical and angiosarcoma: a retrospective study of 18 cases (1998-2003), J Am
pathological features of primary cardiac hemangiosarcoma in dogs: 59. Culp WT, Drobatz KJ, Glassman MM, et al.: Feline visceral hem-
a review of 51 cases, J Vet Med Sci 75:1433–1441, 2013. angiosarcoma, J Vet Intern Med 22:148–152, 2008.
37. Mullin CM, Arkans MA, Sammarco CD, et al.: Doxorubicin che- 60. Sharpe A, Cannon MJ, Lucke VM, et al.: Intestinal haemangio-
motherapy for presumptive cardiac hemangiosarcoma in dogs, Vet sarcoma in the cat: clinical and pathological features of four cases,
Comp Oncol 14:e171–e183, 2016. J Small Anim Pract 41:411–415, 2000.
38. Ward H, Fox LE, Calderwood-Mays MB, et al.: Cutaneous hem- 61. Pirie CG, Dubielzig RR: Feline conjunctival hemangioma and
angiosarcoma in 25 dogs: a retrospective study, J Vet Intern Med hemangiosarcoma: a retrospective evaluation of eight cases (1993-
8:345–348, 1994. 2004), Vet Ophthalmol 9:227–231, 2006.
39. Aupperle H, Marz I, Ellenberger C, et al.: Primary and secondary 62. Wobeser BK, Kidney BA, Powers BE, et al.: Diagnoses and clini-
heart tumours in dogs and cats, J Comp Pathol 136:18–26, 2007. cal outcomes associated with surgically amputated feline digits
40. Locke JE, Barber LG: Comparative aspects and clinical outcomes of submitted to multiple veterinary diagnostic laboratories, Vet Pathol
canine renal hemangiosarcoma, J Vet Intern Med 20:962–967, 2006. 44:362–365, 2007.
41. Liptak JM, Dernell WS, Ehrhart EJ, et al.: Retroperitoneal sarco- 63. Newkirk KM, Rohrbach BW: A retrospective study of eyelid
mas in dogs: 14 cases (1992-2002), J Am Vet Med Assoc 224:1471– tumors from 43 cats, Vet Pathol 46:916–927, 2009.
1477, 2004. 64. von Beust BR, Suter MM, Summers BA: Factor VIII-related anti-
42. Giuffrida MA, Bacon NJ, Kamstock DA: Use of routine histo- gen in canine endothelial neoplasms: an immunohistochemical
pathology and factor VIII-related antigen/von Willebrand factor study, Vet Pathol 25:251–255, 1988.
immunohistochemistry to differentiate primary hemangiosarcoma 65. Ferrer L, Fondevila D, Rabanal RM, et al.: Immunohistochemical
of bone from telangiectatic osteosarcoma in 54 dogs, Vet Comp detection of CD31 antigen in normal and neoplastic canine endo-
Oncol 15:1232–1239, 2017. thelial cells, J Comp Pathol 112:319–326, 1995.
43. Deleted in proof. 66. Bulakowski EJ, Philibert JC, Siegal S, et al.: Evaluation of outcome
44. Dennis MM, Ehrhart N, Duncan CG, et al.: Frequency of and risk associated with subcutaneous and intramuscular hemangiosarcoma
factors associated with lingual lesions in dogs: 1,196 cases (1995- treated with adjuvant doxorubicin in dogs: 21 cases (2001-2006),
2004), J Am Vet Med Assoc 228:1533–1537, 2006. J Am Vet Med Assoc 233:122–128, 2008.
45. Fujita M, Takaishi Y, Yasuda D, et al.: Intranasal hemangiosarcoma 67. Wiley JL, Rook KA, Clifford CA, et al.: Efficacy of doxorubicin-
in a dog, J Vet Med Sci 70:525–528, 2008. based chemotherapy for non-resectable canine subcutaneous haem-
46. Pirie CG, Knollinger AM, Thomas CB, et al.: Canine conjunctival angiosarcoma, Vet Comp Oncol 8:221–233, 2010.
hemangioma and hemangiosarcoma: a retrospective evaluation of 68. Shiu KB, Flory AB, Anderson CL, et al.: Predictors of outcome
108 cases (1989-2004), Vet Ophthalmol 9:215–226, 2006. in dogs with subcutaneous or intramuscular hemangiosarcoma,
47. Liptak JM, Dernell WS, Withrow SJ: Haemangiosarcoma of the J Am Vet Med Assoc 238:472–479, 2011.
urinary bladder in a dog, Aust Vet J 82:215–217, 2004. 69. Culp WT, Weisse C, Kellogg ME, et al.: Spontaneous hemoperito-
48. Wobeser BK, Kidney BA, Powers BE, et al.: Diagnoses and clini- neum in cats: 65 cases (1994-2006), J Am Med Assoc 236:978–982,
cal outcomes associated with surgically amputated canine digits 2010.
submitted to multiple veterinary diagnostic laboratories, Vet Pathol 70. Childress MO: Hematologic abnormalities in the small animal
44:355–361, 2007. cancer patient, Vet Clin North Am Small Anim Pract 42:123–155,
49. Pintar J, Breitschwerdt EB, Hardie EM, et al.: Acute nontraumatic 2012.
hemoabdomen in the dog: a retrospective analysis of 39 cases 71. Warry E, Bohn A, Emanuelli, et al.: Disease distribution in canine
(1987-2001), J Am Anim Hosp Assoc 39:518–522, 2003. patients with acanthocytosis: 123 cases, Vet Clin Pathol 42:465–
50. Hammond TN, Pesillo-Crosby SA: Prevalence of hemangiosar- 470, 2013.
coma in anemic dogs with a splenic mass and hemoperitoneum 72. Hargis AM, Feldman BF: Evaluation of hemostatic defects second-
requiring a transfusion: 71 cases (2003-2005), J Am Vet Med Assoc ary to vascular tumors in dogs: 11 cases (1983-1988), J Am Vet Med
232:553–558, 2008. Assoc 198:891–894, 1991.
51. Aronsohn MG, Dubiel B, Roberts B, et al.: Prognosis for acute 73. Maruyama H, Miura T, Sakai M, et al.: The incidence of dissemi-
nontraumatic hemoperitoneum in the dog: a retrospective analysis nated intravascular coagulation in dogs with malignant tumor, J Vet
of 60 cases (2003-2006), J Am Anim Hosp Assoc 45:72–77, 2009. Med Sci 66:573–575, 2004.
52. Mallinckrodt MJ, Gottfried SD: Mass-to-splenic volume ratio and 74. Wrigley RH, Park RD, Konde LJ, et al.: Ultrasonographic features
splenic weight as a percentage of body weight in dogs with malignant of splenic hemangiosarcoma in dogs: 18 cases (1980-1986), J Am
and benign splenic masses: 65 cases (2007–2008), J Am Vet Med Assoc Vet Med Assoc 192:1113–1117, 1988.
239:1325–1327, 2011. 75. Cuccovillo A, Lamb CR: Cellular features of sonographic target
53. Boston SE, Higginson G, Monteith G: Concurrent splenic and lesions of the liver and spleen in 21 dogs and a cat, Vet Radiol Ultra-
right atrial mass at presentation in dogs with HSA: a retrospective sound 43:275–278, 2002.
study, J Am Anim Hosp Assoc 47:336–341, 2011. 76. O’Brien RT: Improved detection of metastatic hepatic hemangio-
54. Snyder JM, Lipitz L, Skorupski KA, et al.: Secondary intracranial sarcoma nodules with contrast ultrasound in three dogs, Vet Rad
neoplasia in the dog: 177 cases (1986-2003), J Vet Intern Med Ultrasound 48:146–148, 2007.
22:172–177, 2008. 77. Ohlerth S, Dennler M, Ruefli E, et al.: Contrast harmonic imag-
55. Scavelli TD, Patnaik AK, Mehlhaff CJ, et al.: Hemangiosarcoma in ing characterization of canine splenic lesions, J Vet Intern Med
the cat: retrospective evaluation of 31 surgical cases, J Am Vet Med 22:1095–1102, 2008.
Assoc 187:817–819, 1985. 78. Holt D, Van Winkle T, Schelling C, et al.: Correlation between
56. Miller MA, Ramos JA, Kreeger JM: Cutaneous vascular neoplasia thoracic radiographs and postmortem findings in dogs with heman-
in 15 cats: clinical, morphologic, and immunohistochemical stud- giosarcoma: 77 cases (1984-1989), J Am Vet Med Assoc 200:1535–
ies, Vet Pathol 29:329–336, 1992. 1539, 1992.